Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Cancer Genet. 2012 Sep;205(9):453–458. doi: 10.1016/j.cancergen.2012.07.016

Figure 2.

Figure 2

Twenty two patients with t(8;14)(q11.2;q32) had 5 years event-free-survival of 70.6 ±14.4% (a) and 5 years overall-survival of 76.3 ±13.1% (b).